Clinical Trials Browser

Phase EARLY_PHASE1 × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × 90 days × Clear all

NCT04494113 2026-05-13

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Phase EARLY_PHASE1 Active not recruiting

Endometrial Serous Adenocarcinoma